Skip to main content
Top
Published in: Trials 1/2014

Open Access 01-12-2014 | Study protocol

Launching a salt substitute to reduce blood pressure at the population level: a cluster randomized stepped wedge trial in Peru

Authors: Antonio Bernabe-Ortiz, Francisco Diez-Canseco, Robert H Gilman, María K Cárdenas, Katherine A Sacksteder, J Jaime Miranda

Published in: Trials | Issue 1/2014

Login to get access

Abstract

Background

Controlling hypertension rates and maintaining normal blood pressure, particularly in resource-constrained settings, represent ongoing challenges of effective and affordable implementation in health care. One of the strategies being largely advocated to improve high blood pressure calls for salt reduction strategies. This study aims to estimate the impact of a population-level intervention based on sodium reduction and potassium increase – in practice, introducing a low-sodium, high-potassium salt substitute – on adult blood pressure levels.

Methods/Design

The proposed implementation research study includes two components: Phase 1, an exploratory component, and Phase 2, an intervention component. The exploratory component involves a triangle taste test and a formative research study designed to gain an understanding of the best implementation methods. Phase 2 involves a pragmatic stepped wedge trial design where the intervention will be progressively implemented in several clusters starting the intervention randomly at different times. In addition, we will evaluate the implementation strategy using a cost-effectiveness analysis.

Discussion

This is the first project in a Latin-American setting to implement a salt substitution intervention at the population level to tackle high blood pressure. Data generated and lessons learnt from this study will provide a strong platform to address potential interventions applicable to other similar low- and middle-income settings.

Trial registration

This study is registered in ClinicalTrials.gov NCT01960972.
Appendix
Available only for authorised users
Literature
1.
go back to reference Anand SS, Yusuf S: Stemming the global tsunami of cardiovascular disease. Lancet. 2011, 377: 529-532. 10.1016/S0140-6736(10)62346-X.CrossRefPubMed Anand SS, Yusuf S: Stemming the global tsunami of cardiovascular disease. Lancet. 2011, 377: 529-532. 10.1016/S0140-6736(10)62346-X.CrossRefPubMed
2.
go back to reference Yusuf S, Reddy S, Ounpuu S, Anand S: Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation. 2001, 104: 2746-2753. 10.1161/hc4601.099487.CrossRefPubMed Yusuf S, Reddy S, Ounpuu S, Anand S: Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation. 2001, 104: 2746-2753. 10.1161/hc4601.099487.CrossRefPubMed
3.
go back to reference Yusuf S, Ounpuu S: Tackling the growing global burden of atherosclerotic cardiovascular diseases. Eur J Cardiovasc Prev Rehabil. 2003, 10: 236-239. 10.1097/00149831-200308000-00003.CrossRefPubMed Yusuf S, Ounpuu S: Tackling the growing global burden of atherosclerotic cardiovascular diseases. Eur J Cardiovasc Prev Rehabil. 2003, 10: 236-239. 10.1097/00149831-200308000-00003.CrossRefPubMed
4.
go back to reference World Health Organization: Global Status Report on Noncommunicable Diseases 2010. 2011, Geneva: World Health Organization World Health Organization: Global Status Report on Noncommunicable Diseases 2010. 2011, Geneva: World Health Organization
5.
go back to reference Beaglehole R, Bonita R, Horton R, Adams C, Alleyne G, Asaria P, Baugh V, Bekedam H, Billo N, Casswell S, Cecchini M, Colagiuri R, Colagiuri S, Collins T, Ebrahim S, Engelgau M, Galea G, Gaziano T, Geneau R, Haines A, Hospedales J, Jha P, Keeling A, Leeder S, Lincoln P, McKee M, Mackay J, Magnusson R, Moodie R, Mwatsama M, Lancet NCD Action Group; NCD Alliance: Priority actions for the non-communicable disease crisis. Lancet. 2011, 377: 1438-1447. 10.1016/S0140-6736(11)60393-0.CrossRefPubMed Beaglehole R, Bonita R, Horton R, Adams C, Alleyne G, Asaria P, Baugh V, Bekedam H, Billo N, Casswell S, Cecchini M, Colagiuri R, Colagiuri S, Collins T, Ebrahim S, Engelgau M, Galea G, Gaziano T, Geneau R, Haines A, Hospedales J, Jha P, Keeling A, Leeder S, Lincoln P, McKee M, Mackay J, Magnusson R, Moodie R, Mwatsama M, Lancet NCD Action Group; NCD Alliance: Priority actions for the non-communicable disease crisis. Lancet. 2011, 377: 1438-1447. 10.1016/S0140-6736(11)60393-0.CrossRefPubMed
6.
go back to reference Committee on the Consequences of Sodium Reduction in Populations: Sodium Intake in Populations. Assessment of Evidence. 2013, Washington, DC: Institute of Medicine of the National Academies Committee on the Consequences of Sodium Reduction in Populations: Sodium Intake in Populations. Assessment of Evidence. 2013, Washington, DC: Institute of Medicine of the National Academies
7.
go back to reference Henney JE, Taylor CL: Boon CS (Eds): Strategies to Reduce Sodium Intake in the United States. Committee on Strategies to Reduce Sodium Intake; Institute of Medicine. 2010, Washington DC: National Academies Press Henney JE, Taylor CL: Boon CS (Eds): Strategies to Reduce Sodium Intake in the United States. Committee on Strategies to Reduce Sodium Intake; Institute of Medicine. 2010, Washington DC: National Academies Press
8.
go back to reference Lewington S, Clarke R, Qizilbash N, Peto R, Collins R: Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 1903–1913, 2002: 360- Lewington S, Clarke R, Qizilbash N, Peto R, Collins R: Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 1903–1913, 2002: 360-
9.
go back to reference Aburto NJ, Ziolkovska A, Hooper L, Elliott P, Cappuccio FP, Meerpohl JJ: Effect of lower sodium intake on health: systematic review and meta-analyses. BMJ. 2013, 346: f1326-10.1136/bmj.f1326.CrossRefPubMedPubMedCentral Aburto NJ, Ziolkovska A, Hooper L, Elliott P, Cappuccio FP, Meerpohl JJ: Effect of lower sodium intake on health: systematic review and meta-analyses. BMJ. 2013, 346: f1326-10.1136/bmj.f1326.CrossRefPubMedPubMedCentral
10.
go back to reference He FJ, Li J, Macgregor GA: Effect of longer-term modest salt reduction on blood pressure. Cochrane Database Syst Rev. 2013, 4: CD004937 He FJ, Li J, Macgregor GA: Effect of longer-term modest salt reduction on blood pressure. Cochrane Database Syst Rev. 2013, 4: CD004937
11.
go back to reference Taylor RS, Ashton KE, Moxham T, Hooper L, Ebrahim S: Reduced dietary salt for the prevention of cardiovascular disease. Cochrane Database Syst Rev. 2011, 7: CD009217 Taylor RS, Ashton KE, Moxham T, Hooper L, Ebrahim S: Reduced dietary salt for the prevention of cardiovascular disease. Cochrane Database Syst Rev. 2011, 7: CD009217
12.
go back to reference Iestra JA, Kromhout D, van der Schouw YT, Grobbee DE, Boshuizen HC, van Staveren WA: Effect size estimates of lifestyle and dietary changes on all-cause mortality in coronary artery disease patients: a systematic review. Circulation. 2005, 112: 924-934. 10.1161/CIRCULATIONAHA.104.503995.CrossRefPubMed Iestra JA, Kromhout D, van der Schouw YT, Grobbee DE, Boshuizen HC, van Staveren WA: Effect size estimates of lifestyle and dietary changes on all-cause mortality in coronary artery disease patients: a systematic review. Circulation. 2005, 112: 924-934. 10.1161/CIRCULATIONAHA.104.503995.CrossRefPubMed
13.
go back to reference Geleijnse JM, Kok FJ, Grobbee DE: Blood pressure response to changes in sodium and potassium intake: a metaregression analysis of randomised trials. J Hum Hypertens. 2003, 17: 471-480. 10.1038/sj.jhh.1001575.CrossRefPubMed Geleijnse JM, Kok FJ, Grobbee DE: Blood pressure response to changes in sodium and potassium intake: a metaregression analysis of randomised trials. J Hum Hypertens. 2003, 17: 471-480. 10.1038/sj.jhh.1001575.CrossRefPubMed
14.
go back to reference Hooper L, Bartlett C, Davey Smith G, Ebrahim S: Systematic review of long term effects of advice to reduce dietary salt in adults. BMJ. 2002, 325: 628-10.1136/bmj.325.7365.628.CrossRefPubMedPubMedCentral Hooper L, Bartlett C, Davey Smith G, Ebrahim S: Systematic review of long term effects of advice to reduce dietary salt in adults. BMJ. 2002, 325: 628-10.1136/bmj.325.7365.628.CrossRefPubMedPubMedCentral
15.
go back to reference Mitka M, IOM report: Evidence fails to support guidelines for dietary salt reduction. JAMA. 2013, 309: 2535-2536. 10.1001/jama.2013.7110.CrossRefPubMed Mitka M, IOM report: Evidence fails to support guidelines for dietary salt reduction. JAMA. 2013, 309: 2535-2536. 10.1001/jama.2013.7110.CrossRefPubMed
16.
go back to reference Zhao X, Ke L, Li S, Li N, Yan LL, Ba S, He F, Neal B, Wu Y: Effects on Blood Pressure of a Low-Sodium, High Potassium Salt Substitute Among Tibetan Chinese: A Randomized Controlled Trial. In World Congress of Cardiology Scientific Sessions. 2010, American Heart Association: Dallas, TX Zhao X, Ke L, Li S, Li N, Yan LL, Ba S, He F, Neal B, Wu Y: Effects on Blood Pressure of a Low-Sodium, High Potassium Salt Substitute Among Tibetan Chinese: A Randomized Controlled Trial. In World Congress of Cardiology Scientific Sessions. 2010, American Heart Association: Dallas, TX
17.
go back to reference Zhou B, Wang HL, Wang WL, Wu XM, Fu LY, Shi JP: Long-term effects of salt substitution on blood pressure in a rural north Chinese population. J Hum Hypertens. 2013, 27: 427-433. 10.1038/jhh.2012.63.CrossRefPubMed Zhou B, Wang HL, Wang WL, Wu XM, Fu LY, Shi JP: Long-term effects of salt substitution on blood pressure in a rural north Chinese population. J Hum Hypertens. 2013, 27: 427-433. 10.1038/jhh.2012.63.CrossRefPubMed
18.
go back to reference World Health Organization: Guideline: Sodium Intake for Adults and Children. World Health Organization. 2012, Geneva: WHO World Health Organization: Guideline: Sodium Intake for Adults and Children. World Health Organization. 2012, Geneva: WHO
19.
go back to reference DeSimone JA, Beauchamp GK, Drewnowski A, Johnson GH: Sodium in the food supply: challenges and opportunities. Nutr Rev. 2013, 71: 52-59. 10.1111/nure.12006.CrossRefPubMed DeSimone JA, Beauchamp GK, Drewnowski A, Johnson GH: Sodium in the food supply: challenges and opportunities. Nutr Rev. 2013, 71: 52-59. 10.1111/nure.12006.CrossRefPubMed
21.
go back to reference Saavedra-Garcia L, Bernabe-Ortiz A, Diez-Canseco F, Miranda J: Get the facts: Do we know how much is the average salt intake and what are its sources?. Rev Peru Med Exp Salud Publica. 2014, In Press Saavedra-Garcia L, Bernabe-Ortiz A, Diez-Canseco F, Miranda J: Get the facts: Do we know how much is the average salt intake and what are its sources?. Rev Peru Med Exp Salud Publica. 2014, In Press
22.
go back to reference Hawkes C, Webster J: National approaches to monitoring population salt intake: a trade-off between accuracy and practicality?. PLoS One. 2012, 7: e46727-10.1371/journal.pone.0046727.CrossRefPubMedPubMedCentral Hawkes C, Webster J: National approaches to monitoring population salt intake: a trade-off between accuracy and practicality?. PLoS One. 2012, 7: e46727-10.1371/journal.pone.0046727.CrossRefPubMedPubMedCentral
24.
go back to reference Bi J: Sensory Discrimination Tests and Measurements: Statistical Principles, Procedures and Tables. 2006, Iowa: Blackwell Publishing Ltd Bi J: Sensory Discrimination Tests and Measurements: Statistical Principles, Procedures and Tables. 2006, Iowa: Blackwell Publishing Ltd
25.
go back to reference Meilgaard M, Civille GV, Carr BT: Sensory Evaluation Techniques. 1999, NY: CRC Press, 3CrossRef Meilgaard M, Civille GV, Carr BT: Sensory Evaluation Techniques. 1999, NY: CRC Press, 3CrossRef
27.
go back to reference Campbell MK, Piaggio G, Elbourne DR, Altman DG: CONSORT 2010 statement: extension to cluster randomised trials. BMJ. 2012, 345: e5661-10.1136/bmj.e5661.CrossRefPubMed Campbell MK, Piaggio G, Elbourne DR, Altman DG: CONSORT 2010 statement: extension to cluster randomised trials. BMJ. 2012, 345: e5661-10.1136/bmj.e5661.CrossRefPubMed
28.
go back to reference Miranda JJ, Bernabe-Ortiz A, Smeeth L, Gilman RH, Checkley W: Addressing geographical variation in the progression of non-communicable diseases in Peru: the CRONICAS cohort study protocol. BMJ Open. 2012, 2: e000610-CrossRefPubMedPubMedCentral Miranda JJ, Bernabe-Ortiz A, Smeeth L, Gilman RH, Checkley W: Addressing geographical variation in the progression of non-communicable diseases in Peru: the CRONICAS cohort study protocol. BMJ Open. 2012, 2: e000610-CrossRefPubMedPubMedCentral
29.
go back to reference Miranda JJ, Gilman RH, Smeeth L: Differences in cardiovascular risk factors in rural, urban and rural-to-urban migrants in Peru. Heart. 2011, 97: 787-796. 10.1136/hrt.2010.218537.CrossRefPubMedPubMedCentral Miranda JJ, Gilman RH, Smeeth L: Differences in cardiovascular risk factors in rural, urban and rural-to-urban migrants in Peru. Heart. 2011, 97: 787-796. 10.1136/hrt.2010.218537.CrossRefPubMedPubMedCentral
30.
go back to reference Hussey MA, Hughes JP: Design and analysis of stepped wedge cluster randomized trials. Contemp Clin Trials. 2007, 28: 182-191. 10.1016/j.cct.2006.05.007.CrossRefPubMed Hussey MA, Hughes JP: Design and analysis of stepped wedge cluster randomized trials. Contemp Clin Trials. 2007, 28: 182-191. 10.1016/j.cct.2006.05.007.CrossRefPubMed
31.
go back to reference Hughes JP, Goldenberg RL, Wilfert CM, Valentine M, Mwinga KG, Guay LA, Mimiro F, Stringer JSA: Design of the HIV Prevention Trials Network (HPTN) Protocol 054: A Cluster Randomized Crossover Trial to Evaluate Combined Access to Nevirapine in Developing Countries. Technical Report 195. 2003, Washington: University of Washington, Department of Biostatistics Hughes JP, Goldenberg RL, Wilfert CM, Valentine M, Mwinga KG, Guay LA, Mimiro F, Stringer JSA: Design of the HIV Prevention Trials Network (HPTN) Protocol 054: A Cluster Randomized Crossover Trial to Evaluate Combined Access to Nevirapine in Developing Countries. Technical Report 195. 2003, Washington: University of Washington, Department of Biostatistics
32.
go back to reference Mason R, Nottingham S: Sensory Evaluation Manual. 2002, Queensland: The University of Queensland Mason R, Nottingham S: Sensory Evaluation Manual. 2002, Queensland: The University of Queensland
33.
go back to reference Glaser BG: Doing Grounded Theory: Issues and Discussions. 1998, Mill Valley: CSP Glaser BG: Doing Grounded Theory: Issues and Discussions. 1998, Mill Valley: CSP
34.
go back to reference Strauss AL, Corbin J: Basics of Qualitative Research: Grounded Theory Procedures and Techniques. 1998, Thousand Oaks: CSP, 2 Strauss AL, Corbin J: Basics of Qualitative Research: Grounded Theory Procedures and Techniques. 1998, Thousand Oaks: CSP, 2
35.
go back to reference Fitzmaurice GM, Laird NM, Ware JH: Applied Longitudinal Analysis. 2011, New Jersey: Wiley, 2 Fitzmaurice GM, Laird NM, Ware JH: Applied Longitudinal Analysis. 2011, New Jersey: Wiley, 2
36.
go back to reference Hardin JW, Hill JM: Generalized Estimating Equations. 2002, Chapman & Hall/CRC: FloridaCrossRef Hardin JW, Hill JM: Generalized Estimating Equations. 2002, Chapman & Hall/CRC: FloridaCrossRef
38.
go back to reference Musgrove P, Fox-Rushby J: Disease Control Priorities in Developing Countries. 2006, Washington: Oxford University Press and The World Bank Musgrove P, Fox-Rushby J: Disease Control Priorities in Developing Countries. 2006, Washington: Oxford University Press and The World Bank
39.
go back to reference Suhrcke M, Boluarte TA, Niessen L: A systematic review of economic evaluations of interventions to tackle cardiovascular disease in low- and middle-income countries. BMC Public Health. 2012, 12: 2-10.1186/1471-2458-12-2.CrossRefPubMedPubMedCentral Suhrcke M, Boluarte TA, Niessen L: A systematic review of economic evaluations of interventions to tackle cardiovascular disease in low- and middle-income countries. BMC Public Health. 2012, 12: 2-10.1186/1471-2458-12-2.CrossRefPubMedPubMedCentral
41.
go back to reference Geleijnse JM, Witteman JC, Bak AA, den Breeijen JH, Grobbee DE: Reduction in blood pressure with a low sodium, high potassium, high magnesium salt in older subjects with mild to moderate hypertension. BMJ. 1994, 309: 436-440. 10.1136/bmj.309.6952.436.CrossRefPubMedPubMedCentral Geleijnse JM, Witteman JC, Bak AA, den Breeijen JH, Grobbee DE: Reduction in blood pressure with a low sodium, high potassium, high magnesium salt in older subjects with mild to moderate hypertension. BMJ. 1994, 309: 436-440. 10.1136/bmj.309.6952.436.CrossRefPubMedPubMedCentral
42.
go back to reference Sacks FM, Svetkey LP, Vollmer WM, Appel LJ, Bray GA, Harsha D, Obarzanek E, Conlin PR, Miller ER, Simons-Morton DG, Karanja N, Lin PH, DASH-Sodium Collaborative Research Group: Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med. 2001, 344: 3-10.PubMed Sacks FM, Svetkey LP, Vollmer WM, Appel LJ, Bray GA, Harsha D, Obarzanek E, Conlin PR, Miller ER, Simons-Morton DG, Karanja N, Lin PH, DASH-Sodium Collaborative Research Group: Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med. 2001, 344: 3-10.PubMed
43.
go back to reference Cook NR, Cutler JA, Obarzanek E, Buring JE, Rexrode KM, Kumanyika SK, Appel LJ, Whelton PK: Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the trials of hypertension prevention (TOHP). BMJ. 2007, 334: 885-888. 10.1136/bmj.39147.604896.55.CrossRefPubMedPubMedCentral Cook NR, Cutler JA, Obarzanek E, Buring JE, Rexrode KM, Kumanyika SK, Appel LJ, Whelton PK: Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the trials of hypertension prevention (TOHP). BMJ. 2007, 334: 885-888. 10.1136/bmj.39147.604896.55.CrossRefPubMedPubMedCentral
44.
go back to reference Whelton PK, Buring J, Borhani NO, Cohen JD, Cook N, Cutler JA, Kiley JE, Kuller LH, Satterfield S, Sacks FM, Taylor JO, Trials of Hypertension Prevention (TOHP) Collaborative Research Group: The effect of potassium supplementation in persons with a high-normal blood pressure. Results from phase I of the Trials of Hypertension Prevention (TOHP). Trials of Hypertension Prevention (TOHP) Collaborative Research Group. Ann Epidemiol. 1995, 5: 85-95. 10.1016/1047-2797(94)00053-V.CrossRefPubMed Whelton PK, Buring J, Borhani NO, Cohen JD, Cook N, Cutler JA, Kiley JE, Kuller LH, Satterfield S, Sacks FM, Taylor JO, Trials of Hypertension Prevention (TOHP) Collaborative Research Group: The effect of potassium supplementation in persons with a high-normal blood pressure. Results from phase I of the Trials of Hypertension Prevention (TOHP). Trials of Hypertension Prevention (TOHP) Collaborative Research Group. Ann Epidemiol. 1995, 5: 85-95. 10.1016/1047-2797(94)00053-V.CrossRefPubMed
45.
go back to reference Whelton PK, He J, Cutler JA, Brancati FL, Appel LJ, Follmann D, Klag MJ: Effects of oral potassium on blood pressure. Meta-analysis of randomized controlled clinical trials. JAMA. 1997, 277: 1624-1632.PubMed Whelton PK, He J, Cutler JA, Brancati FL, Appel LJ, Follmann D, Klag MJ: Effects of oral potassium on blood pressure. Meta-analysis of randomized controlled clinical trials. JAMA. 1997, 277: 1624-1632.PubMed
46.
go back to reference Dickinson HO, Nicolson DJ, Campbell F, Beyer FR, Mason J: Potassium supplementation for the management of primary hypertension in adults. Cochrane Database Syst Rev. 2006, 3: CD004641 Dickinson HO, Nicolson DJ, Campbell F, Beyer FR, Mason J: Potassium supplementation for the management of primary hypertension in adults. Cochrane Database Syst Rev. 2006, 3: CD004641
47.
go back to reference He FJ, MacGregor GA: A comprehensive review on salt and health and current experience of worldwide salt reduction programmes. J Hum Hypertens. 2009, 23: 363-384. 10.1038/jhh.2008.144.CrossRefPubMed He FJ, MacGregor GA: A comprehensive review on salt and health and current experience of worldwide salt reduction programmes. J Hum Hypertens. 2009, 23: 363-384. 10.1038/jhh.2008.144.CrossRefPubMed
48.
go back to reference China Salt Substitute Study Collaborative Group: Salt substitution: a low-cost strategy for blood pressure control among rural Chinese. A randomized, controlled trial. J Hypertens. 2007, 25: 2011-2018.CrossRef China Salt Substitute Study Collaborative Group: Salt substitution: a low-cost strategy for blood pressure control among rural Chinese. A randomized, controlled trial. J Hypertens. 2007, 25: 2011-2018.CrossRef
49.
go back to reference Murray CJ, Lauer JA, Hutubessy RC, Niessen L, Tomijima N, Rodgers A, Lawes CM, Evans DB: Effectiveness and costs of interventions to lower systolic blood pressure and cholesterol: a global and regional analysis on reduction of cardiovascular-disease risk. Lancet. 2003, 361: 717-725. 10.1016/S0140-6736(03)12655-4.CrossRefPubMed Murray CJ, Lauer JA, Hutubessy RC, Niessen L, Tomijima N, Rodgers A, Lawes CM, Evans DB: Effectiveness and costs of interventions to lower systolic blood pressure and cholesterol: a global and regional analysis on reduction of cardiovascular-disease risk. Lancet. 2003, 361: 717-725. 10.1016/S0140-6736(03)12655-4.CrossRefPubMed
50.
go back to reference Pearson TA, Bazzarre TL, Daniels SR, Fair JM, Fortmann SP, Franklin BA, Goldstein LB, Hong Y, Mensah GA, Sallis JF, Smith S, Stone NJ, Taubert KA, American Heart Association Expert Panel on Population and Prevention Science: American Heart Association guide for improving cardiovascular health at the community level: a statement for public health practitioners, healthcare providers, and health policy makers from the American Heart Association Expert Panel on Population and Prevention Science. Circulation. 2003, 107: 645-651. 10.1161/01.CIR.0000054482.38437.13.CrossRefPubMed Pearson TA, Bazzarre TL, Daniels SR, Fair JM, Fortmann SP, Franklin BA, Goldstein LB, Hong Y, Mensah GA, Sallis JF, Smith S, Stone NJ, Taubert KA, American Heart Association Expert Panel on Population and Prevention Science: American Heart Association guide for improving cardiovascular health at the community level: a statement for public health practitioners, healthcare providers, and health policy makers from the American Heart Association Expert Panel on Population and Prevention Science. Circulation. 2003, 107: 645-651. 10.1161/01.CIR.0000054482.38437.13.CrossRefPubMed
Metadata
Title
Launching a salt substitute to reduce blood pressure at the population level: a cluster randomized stepped wedge trial in Peru
Authors
Antonio Bernabe-Ortiz
Francisco Diez-Canseco
Robert H Gilman
María K Cárdenas
Katherine A Sacksteder
J Jaime Miranda
Publication date
01-12-2014
Publisher
BioMed Central
Published in
Trials / Issue 1/2014
Electronic ISSN: 1745-6215
DOI
https://doi.org/10.1186/1745-6215-15-93

Other articles of this Issue 1/2014

Trials 1/2014 Go to the issue